MedMira Inc V.MIR

Alternate Symbol(s): MMIRF

Healthcare Medical Devices

MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. It provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.

TSXV:MIR - Post by User

MedMira Inc

Bullboard Posts

Post by Schmidon Jun 20, 2020 10:47pm

242 Views

Post# 31173782

Super Spreader Event Just Ended in Tulsa

Trump hailed for his stand-up comedy talents. Oklahoma's ICU availability 32%
The U.S.A. experiencing new highs everyday in new cases and deaths brought on by lack of care since memorial day by many, demonstrations and bi-partisian politicians providing mixed messaging and proper diligence in protecting citizens.

In Canada, in spite of Liberal Govts inempt responses, the provinces have all managed to bring Covid 19 under control through health measures, physical distancing, testing and rigorous contact tracing.

MIR has a high quality test like no other and awaits FDA EUA greenlight. What people on this board are forgetting is Covid 19 is also infecting alarming portions of the population across the globe right now, mainly in 3rd world countries like India, Indonesia and many African states.

I expect news of foreign sales may come before FDA greenlight, as MIR has attached CE Mark to it's test May 21, allowing sales in many of these countries and Europe since that time. IMO, purchase orders are in the works and could be announced at any time. GLTA

May 27, 2020

MedMira Announces Exclusive Distribution Partnership with Webb Diagnostic Technologies and Initial Order for REVEALCOVID-19™ Total Antibody Test in the U.S.

Halifax, Nova Scotia, 27 May, 2020 – MedMira Inc. (MedMira) (TSXV: MIR) announces that company has entered into an Exclusive Distribution Agreement with Webb Diagnostic Technologies, Inc., (WebbDX) for the distribution of MedMira’s REVEALCOVID-19™ Total Antibody Test. Webb Diagnostic Technologies has placed the first order with the purchase value of approximately CDN$3.5 million. The Company has received the down payment to initiate the production process.

May 21, 2020

MedMira Announces Progress Update of its REVEALCOVID-19TM Total Antibody test including CE mark

Halifax, Nova Scotia, 21. May, 2020 – Today, MedMira Inc. (MedMira) (TSXV: MIR) announced that it has completed the registration process and affixed the CE mark (Conformit Europene) to its rapid REVEALCOVID- 19TM Total Antibody Test.

April 23, 2020

MedMira Announces Notification Submission to US FDA Emergency Use Authorization

MedMira Inc. announced today that it had submitted the notification for the Emergency Use Authorization application offered by the U.S. Food and Drug Administration (FDA) for its newest member of its Reveal line of products for antibody testing.

Bullboard Posts

Gold vs. bitcoin, where should you invest?